What was the market valuation of the UK central venous-catheter market in 2024?

The market valuation was $80.29 Million in 2024. Read More

What is the projected market valuation for the UK central venous-catheter market by 2035?

The projected valuation for 2035 is $142.45 Million. Read More

What is the expected CAGR for the UK central venous-catheter market during the forecast period 2025 - 2035?

The expected CAGR is 5.35% during the forecast period 2025 - 2035. Read More

Which product type segment had the highest valuation in 2024?

The Tunneled Catheters segment had a valuation of $50.29 Million in 2024. Read More

What are the valuations for Non-Antimicrobial Catheters in 2024?

The valuations for Non-Antimicrobial Catheters ranged from $40.14 Million to $70.12 Million in 2024. Read More

Which design segment is projected to grow significantly by 2035?

The Multi Lumen design segment is projected to grow from $30.0 Million in 2024 to a higher valuation by 2035. Read More

Who are the key players in the UK central venous-catheter market?

Key players include Becton Dickinson and Company, Medtronic plc, and Boston Scientific Corporation. Read More

What was the valuation range for Silicone catheters in 2024?

The valuation range for Silicone catheters was $35.0 Million to $60.0 Million in 2024. Read More

How does the valuation of Antimicrobial Catheters compare to Non-Antimicrobial Catheters in 2024?

Antimicrobial Catheters had a valuation range of $32.23 Million to $55.56 Million, lower than Non-Antimicrobial Catheters. Read More

What is the significance of the projected growth in the UK central venous-catheter market?

The projected growth indicates a rising demand for central venous catheters, reflecting advancements in medical technology and patient care. Read More

UK Central Venous Catheter Market

ID: MRFR/MED/50712-HCR

200 Pages

Vikita Thakur

Last Updated: February 06, 2026

UK Central Venous Catheter Market Research Report: Size, Share, Trend Analysis By Product Type (Non-tunneled Catheters, Tunneled Catheters), By Property (Non-Antimicrobial Catheters, Antimicrobial Catheters, Others), By Design (Multi Lumen, Double Lumen, Single Lumen) and By Composition (Polyurethane, Silicone, Others) - Growth Outlook & Industry Forecast 2025 To 2035

UK Central Venous Catheter Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)5.35%

2024 Market Size$ 80.29 Million

2025 Market Size$ 84.59 Million

2035 Market Size$ 142.45 Million

Key Players

Becton Dickinson and Company

Medtronic plc

Boston Scientific Corporation

Teleflex Incorporated

Smiths Medical

Vygon S.A.

Trends

Technological Advancements
Regulatory Focus on Safety
Rising Demand from Healthcare Providers

Opportunities

Advancements in Medical Technology
Expansion of Home Healthcare Services
Rising Awareness of Infection Control

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Product Type (USD Million)
  1. 4.1.1 Non-tunneled Catheters
  2. 4.1.2 Tunneled Catheters
2. 4.2 Healthcare, BY Property (USD Million)
  1. 4.2.1 Non-Antimicrobial Catheters
  2. 4.2.2 Antimicrobial Catheters
  3. 4.2.3 Others
3. 4.3 Healthcare, BY Design (USD Million)
  1. 4.3.1 Multi Lumen
  2. 4.3.2 Double Lumen
  3. 4.3.3 Single Lumen
4. 4.4 Healthcare, BY Composition (USD Million)
  1. 4.4.1 Polyurethane
  2. 4.4.2 Silicone
  3. 4.4.3 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Becton Dickinson and Company (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Medtronic plc (IE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Boston Scientific Corporation (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Teleflex Incorporated (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Smiths Medical (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Vygon S.A. (FR)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Fresenius Kabi AG (DE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 AngioDynamics, Inc. (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY PRODUCT TYPE
3. 6.3 UK MARKET ANALYSIS BY PROPERTY
4. 6.4 UK MARKET ANALYSIS BY DESIGN
5. 6.5 UK MARKET ANALYSIS BY COMPOSITION
6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF HEALTHCARE
9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
12. 6.12 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
13. 6.13 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
14. 6.14 HEALTHCARE, BY PROPERTY, 2024 (% SHARE)
15. 6.15 HEALTHCARE, BY PROPERTY, 2024 TO 2035 (USD Million)
16. 6.16 HEALTHCARE, BY DESIGN, 2024 (% SHARE)
17. 6.17 HEALTHCARE, BY DESIGN, 2024 TO 2035 (USD Million)
18. 6.18 HEALTHCARE, BY COMPOSITION, 2024 (% SHARE)
19. 6.19 HEALTHCARE, BY COMPOSITION, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY PROPERTY, 2025-2035 (USD Million)
  3. 7.2.3 BY DESIGN, 2025-2035 (USD Million)
  4. 7.2.4 BY COMPOSITION, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK Central Venous Catheter Market Segmentation

UK Central Venous Catheter Market By Product Type (USD Million, 2025-2035)

Non-tunneled Catheters
Tunneled Catheters

UK Central Venous Catheter Market By Property (USD Million, 2025-2035)

Non-Antimicrobial Catheters
Antimicrobial Catheters
Others

UK Central Venous Catheter Market By Design (USD Million, 2025-2035)

Multi Lumen
Double Lumen
Single Lumen

UK Central Venous Catheter Market By Composition (USD Million, 2025-2035)

Polyurethane
Silicone
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”